Aim: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality
and permanent disability rates. The overall prognosis depends on the volume of the initial …

Patients with acute ischemic stroke frequently test positive for hyperglycemia, which is
associated with a poor clinical outcome. This association between poor glycemic control and …

Glucose management in intensive care unit (ICU) patients has been a matter of debate for
almost two decades. Compared to intermittent monitoring systems, continuous glucose …

Introduction Hyper-and hypoglycemia are strongly associated with adverse outcomes in
critical care. Neurologically injured patients are a unique subgroup, where optimal glycemic …

Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal
subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a …

There is growing debate over the value of intensive insulin therapy (IIT) in critically ill
patients. Available trials have been performed in general medical or surgical intensive care …

Background Aneurysmal subarachnoid hemorrhage is a life-threatening disease requiring
neurocritical care. Delayed cerebral ischemia is a well-known complication that contributes …

Background Subarachnoid hemorrhage (SAH) is managed across the full spectrum of
healthcare, from clinical diagnosis to management of the hemorrhage and associated …

Object As part of a project to devise evidence-based safety interventions for specialty
surgery, we sought to review current evidence concerning the frequency of adverse events …